WOAG
WITHDRAWAL OF ATTORNEY GRANTED
06/03/2026
Back to search
Official data from USPTO
DUALASE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
06/05/2026
Trademark type
Word
Nice classes
42
Filing date
08/05/2020
Registration date
05/02/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/02/2023
Last transaction
06/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
03/20/2018
First use in commerce
03/20/2018
Drawing code
4
Owner type
03
Owner location
Toronto, Ontario, CA
Examiner
CANTOR, JILLIAN REDDING
Law office
P10
Current location
TMO LAW OFFICE 137
Holders and representatives
Holders
Specific Biologics Inc.
Representatives
Specific Biologics Inc.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical products development; Pharmaceutical research and developmentresearch in the field of gene editing; Pharmaceutical research services; Biomedical research services; Biotechnology researchin the field of genetic editing; Clinical research in the field of gene editing; Drug discovery services; Medical and scientific research in the field of cancer treatment; Medical and scientific research in the field of treatment of rare genetic diseases and disorders; Medical research; Medical research servicesfor the treatment of cystic fibrosis and lung cancer; Providing laboratory research services in the field of gene expressioncancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research in the field of genetic editing; Research on the subject of pharmaceuticalspharmaceuticals to treat genetic disorderscystic fibrosis and lung cancer; Scientific investigations for medical purposes; Scientific research in the field of oncology; Scientific study and research in the field of oncology; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Medical and scientific research in the field of genetic engineeringplatform gene editing technology; Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research in the field of genetics and genetic engineering; Platform as a service (PAAS) featuring computer software platforms for gene editing
Publications
History of USPTO decisions and trademark events.
38 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
06/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/02/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/25/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/24/2023
DOCK
ASSIGNED TO EXAMINER
03/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/17/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/17/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/17/2023
ALIE
ASSIGNED TO LIE
01/17/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/17/2022
GNRT
NON-FINAL ACTION E-MAILED
07/17/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
07/17/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/16/2022
IUAF
USE AMENDMENT FILED
05/10/2022
EISU
TEAS STATEMENT OF USE RECEIVED
05/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/16/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/07/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/12/2021
PUBO
PUBLISHED FOR OPPOSITION
10/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/22/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/09/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
08/11/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/02/2021
ALIE
ASSIGNED TO LIE
07/07/2021
DRRR
DIVISIONAL REQUEST RECEIVED
05/19/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/19/2021
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
05/19/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/29/2020
GNRT
NON-FINAL ACTION E-MAILED
11/29/2020
CNRT
NON-FINAL ACTION WRITTEN
11/29/2020
DOCK
ASSIGNED TO EXAMINER
11/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/04/2020
NWAP
NEW APPLICATION ENTERED
08/08/2020
Continuous trademark protection
Get notified about every new filing that threatens DUALASE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.